Patents Assigned to VivaVisionShanghaiLtd
  • Patent number: 11325929
    Abstract: The present invention provides a phosphorus-containing compound characterized by being a compound represented by the following structure: the compound is a novel immune cell migration inhibitor. The compound has good hydrophilicity and can be developed into eye drops. The compound has a strong inhibitory ability to immune cell migration and can relieve the symptoms of most dry-eye patients.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: May 10, 2022
    Assignee: VivaVisionShanghaiLtd
    Inventors: Wang Shen, Yue Ding, Hao Jiang, Fu li Chen, Jiangfeng Wang, Xinglong Wu, Cunfei Li, Liguo Yang, Biao Hu, Qiyang Jiang, Zhixing An, Kuifeng Dang
  • Publication number: 20200131206
    Abstract: The present invention provides a phosphorus-containing compound characterized by being a compound represented by the following structure: the compound is a novel immune cell migration inhibitor. The compound has good hydrophilicity and can be developed into eye drops. The compound has a strong inhibitory ability to immune cell migration and can relieve the symptoms of most dry-eye patients.
    Type: Application
    Filed: May 21, 2018
    Publication date: April 30, 2020
    Applicant: VivaVisionShanghaiLtd
    Inventors: Wang SHEN, Yue DING, Hao JIANG, Fu li CHEN, Jiangfeng WANG, Xinglong WU, Cunfei LI, Liguo YANG, Biao HU, Qiyang JIANG, Zhixing AN, Kuifeng DANG